As an oncogene that is overactivated, leading to cancer development at a rapid rate, TOPK overexpression is a common molecular characteristic of human malignancies, and it has been reported in many types of human cancers, including colon, lung, esophageal, prostate, and ovarian cancers [9,11,12,13,24]. Here, PBK is linked to ovarian cancer.